Competition : Amgen (AMGN NASDAQ) is developing a once-monthly GLP-1 drug that could provide more convenience for patients and lead to higher adherence
Side effects, long-term considerations and personal medical history all play a role in determining whether a GLP-1 drug is right for you
Anaphylaxis, peripheral neuropathy, hepatotoxicity, thyroid dysfunction, renal stress, injection-site infections, and zinc depletion all documented in peer-reviewed literature
The concern that testosterone therapy might fuel prostate cancer kept many men from a treatment that could have meaningfully improved their quality of life, and new data suggests that fear deserve
Another source of reducing equivalents comes from the selective transport of GSH, rather than GSSG, from the cytosol into the ER lumen
When ready, call (919) 797-0996 to schedule your consultation